ipratropium bromide and albuterol
ipratropium bromide and albuterol is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Combivent Respimat. Available dosage form: spray, metered.
Drug details
- Generic Name
- ipratropium bromide and albuterol
- Brand Names
- Combivent Respimat
- Application Number
- NDA021747
- Sponsor
- Boehringer Ingelheim Pharmaceuticals, Inc.
- NDC Codes
- 1
- Dosage Forms
- SPRAY, METERED
- Routes
- RESPIRATORY (INHALATION)
- Active Ingredients
- IPRATROPIUM BROMIDE, ALBUTEROL SULFATE
Indications and Usage
1 INDICATIONS AND USAGE COMBIVENT RESPIMAT is a combination of ipratropium bromide (an anticholinergic agent) and albuterol sulfate (a beta 2 -adrenergic agonist) indicated for use in patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator. COMBIVENT RESPIMAT Inhalation Spray is a combination of ipratropium bromide (an anticholinergic agent) and albuterol sulfate (a beta 2 ‑adrenergic agonist) indicated for: Patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator (1)